Redcare Pharmacy NV (RDC) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Based on the latest financial reports, Redcare Pharmacy NV (RDC) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€20.70 Million ≈ $24.20 Million USD) by net assets (€468.30 Million ≈ $547.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Redcare Pharmacy NV for the company's overall valuation and market capitalisation.

Redcare Pharmacy NV - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Redcare Pharmacy NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Redcare Pharmacy NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Redcare Pharmacy NV ranked by their cash flow conversion efficiency. Explore Redcare Pharmacy NV cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
KPC Pharmaceuticals Inc SHG:600422	0.017x
Truking Technology Ltd SHE:300358	0.070x
Tortoise Energy Infrastructure Closed Fund NYSE:TYG	0.017x
Hebei Sailhero Environmental SHE:300137	0.020x
Evolv Technologies Holdings Inc NASDAQ:EVLV	0.100x
LGI Homes NASDAQ:LGIH	0.041x
CAP S.A SN:CAP	0.039x
BeiJing Certificate Authority Co Ltd SHE:300579	-0.079x

Annual Cash Flow Conversion Efficiency for Redcare Pharmacy NV (2013–2025)

The table below shows the annual cash flow conversion efficiency of Redcare Pharmacy NV from 2013 to 2025. View Redcare Pharmacy NV (RDC) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€479.20 Million ≈ $560.24 Million	€23.00 Million ≈ $26.89 Million	0.048x	+10.62%
2024-12-31	€509.97 Million ≈ $596.21 Million	€22.13 Million ≈ $25.87 Million	0.043x	-61.03%
2023-12-31	€552.03 Million ≈ $645.38 Million	€61.46 Million ≈ $71.85 Million	0.111x	+235.61%
2022-12-31	€354.63 Million ≈ $414.60 Million	€-29.11 Million ≈ $-34.03 Million	-0.082x	-393.10%
2021-12-31	€415.41 Million ≈ $485.66 Million	€11.63 Million ≈ $13.60 Million	0.028x	-33.11%
2020-12-31	€425.14 Million ≈ $497.03 Million	€17.80 Million ≈ $20.81 Million	0.042x	+132.10%
2019-12-31	€232.76 Million ≈ $272.12 Million	€-30.37 Million ≈ $-35.50 Million	-0.130x	-18.58%
2018-12-31	€213.98 Million ≈ $250.16 Million	€-23.54 Million ≈ $-27.52 Million	-0.110x	-13.11%
2017-12-31	€238.97 Million ≈ $279.38 Million	€-23.24 Million ≈ $-27.17 Million	-0.097x	+47.26%
2016-12-31	€93.25 Million ≈ $109.01 Million	€-17.20 Million ≈ $-20.11 Million	-0.184x	+94.83%
2015-12-31	€2.46 Million ≈ $2.87 Million	€-8.78 Million ≈ $-10.26 Million	-3.570x	-1844.15%
2014-12-31	€20.06 Million ≈ $23.45 Million	€-3.68 Million ≈ $-4.31 Million	-0.184x	+21.73%
2013-12-31	€18.08 Million ≈ $21.14 Million	€-4.24 Million ≈ $-4.96 Million	-0.235x	--

About Redcare Pharmacy NV

XETRA:RDC Germany Pharmaceutical Retailers

Market Cap

$1.42 Billion

€1.22 Billion EUR

Market Cap Rank

#9382 Global

#1171 in Germany

Share Price

€59.90

Change (1 day)

+10.93%

52-Week Range

€30.86 - €87.90

All Time High

€246.00